VALIDATING CONDITIONALLY REPROGRAMMED CELLS TO ADVANCED PERSONALIZED MEDICINE FOR PROSTATE CANCER.

$1,306,200FY2013Department of DefenseDOD

Georgetown University, Washington DC

Investigators